Academic Plastic Surgery Programmes, Centre for Cell Biology & Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Plastic Surgery and Burns Unit, Mater Dei Hospital, Msida, Malta.
J Cosmet Dermatol. 2024 Jun;23(6):1940-1955. doi: 10.1111/jocd.16228. Epub 2024 Feb 15.
Hyperbaric oxygen therapy (HBOT) involves patients breathing 100% oxygen in a pressurized chamber, above 1 atmosphere. Many centers are now promoting the use of HBOT for skin rejuvenation. However, the current indications for HBOT do not encompass aesthetic applications.
The aim of this evidence-based review was to assess the existing literature regarding the utilization of HBOT in medical aesthetics and rejuvenation, evaluate its effectiveness and safety, and conduct a cost analysis.
PubMed Interface, Cochrane Library, Google Scholar, and Embase searches were carried out. The Best Bets methodology was used, and the risk of bias was appraised using the Quality Assessment Tool for Quantitative Studies.
This review included a total of 17 human studies with a total of 766 participants. Three studies were classified as level II evidence, three studies were of level III evidence, and 11 were of level IV evidence. All the included studies were judged at high risk of bias. The most relevant findings supported by level II evidence were that HBOT decreased the shedding rate post-FUE hair transplant (27.6 ± 2.6% vs. 69.1 ± 2.4%) but this did not affect the final outcome between HBOT (96.9 ± 0.5%) and the control (93.8 ± 0.6%). Moreover, level III evidence demonstrated that following HBOT, there was a significant increase in elastic fiber length (p ≤ 0.0001, effect size = 2.71) and a significant decrease in fiber fragmentation (p = 0.012). There was also a significant increase in collagen fiber density following HBOT (p = 0.0001, effect size = 1.10). However, there was no significant effect of antioxidant vitamins A, C, and E with HBOT. The inflammatory response significantly decreased after 7 days of HBOT with a decreased expression of IL-12p40, MIP-1β, and PDGF-BB and a higher expression of IL-1Ra. Moreover, HBOT was used prophylactically prior to abdominoplasty to decrease the risk of complications. In this study, complications were decreased from 32.6% (89 patients) to 8.4% (7 patients) with a p < 0.001, and in a multivariate analysis, preoperative HBOT was an independent protective factor against postoperative complications (p < 0.001).
There is conflicting evidence on how the method of action of HBOT can have a beneficiary effect in aesthetic and whether the treatment is justifiable. To our knowledge, this is the first comprehensive review discussing the available evidence regarding the use of HBOT in many aesthetic clinical scenarios, including preventive, medical, and surgical settings. However, randomized clinical trials with longer follow-up and better patient selection are needed to be able to generate a reliable conclusion.
高压氧治疗(HBOT)涉及患者在高于 1 个大气压的加压舱中呼吸 100%的氧气。现在许多中心正在推广 HBOT 用于皮肤年轻化。然而,HBOT 的现行适应证不包括美容应用。
本循证综述的目的是评估关于 HBOT 在医学美容和年轻化中的应用的现有文献,评估其有效性和安全性,并进行成本分析。
进行了 PubMed 界面、Cochrane 图书馆、Google Scholar 和 Embase 搜索。使用了最佳证据方法,并使用定量研究质量评估工具评估了偏倚风险。
本综述共纳入了 17 项共 766 名参与者的人类研究。其中 3 项研究被归类为二级证据,3 项研究为三级证据,11 项为四级证据。所有纳入的研究均被判定为高偏倚风险。最相关的发现是二级证据支持 HBOT 降低了 FUE 毛发移植后的脱发率(27.6±2.6% vs. 69.1±2.4%),但这并不影响 HBOT(96.9±0.5%)和对照组(93.8±0.6%)的最终结果。此外,三级证据表明,HBOT 后弹性纤维长度显著增加(p≤0.0001,效应大小=2.71),纤维碎裂显著减少(p=0.012)。HBOT 后胶原纤维密度也显著增加(p=0.0001,效应大小=1.10)。然而,抗氧化维生素 A、C 和 E 与 HBOT 联合使用并没有显著效果。HBOT 后 7 天炎症反应明显下降,IL-12p40、MIP-1β 和 PDGF-BB 的表达降低,IL-1Ra 的表达升高。此外,HBOT 还可在腹部整形术前预防性使用,以降低并发症风险。在这项研究中,并发症从 32.6%(89 例患者)降低至 8.4%(7 例患者)(p<0.001),多变量分析显示,术前 HBOT 是预防术后并发症的独立保护因素(p<0.001)。
关于 HBOT 的作用机制如何能对美容产生有益影响,以及治疗是否合理,目前证据相互矛盾。据我们所知,这是第一篇全面综述,讨论了 HBOT 在许多美容临床情况下的应用的现有证据,包括预防、医学和手术环境。然而,需要进行更长时间随访和更好患者选择的随机临床试验,以便能够得出可靠的结论。